Page last updated: 2024-09-03

5-(4-piperidyl)isoxazol-3-ol and valine

5-(4-piperidyl)isoxazol-3-ol has been researched along with valine in 1 studies

Compound Research Comparison

Studies
(5-(4-piperidyl)isoxazol-3-ol)
Trials
(5-(4-piperidyl)isoxazol-3-ol)
Recent Studies (post-2010)
(5-(4-piperidyl)isoxazol-3-ol)
Studies
(valine)
Trials
(valine)
Recent Studies (post-2010) (valine)
210415,4651,1763,932

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaike, N; Murai, Y; Nielsen, M; Noguchi, K; Westh-Hansen, SE; Witt, MR1

Other Studies

1 other study(ies) available for 5-(4-piperidyl)isoxazol-3-ol and valine

ArticleYear
Effects of 5-(4-piperidyl) isoxazol-3-ol (4-PIOL), a GABA(A) receptor partial agonist, on recombinant human GABA(A) receptors.
    Neuroscience letters, 1997, Jul-11, Volume: 230, Issue:1

    Topics: Animals; Cell Line; GABA Agonists; gamma-Aminobutyric Acid; Humans; Isoxazoles; Kinetics; Macromolecular Substances; Membrane Potentials; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Piperidines; Receptors, GABA-A; Recombinant Proteins; Spodoptera; Transfection; Valine

1997